Coloplast A/S Total Liabilities
Coloplast A/S total liabilities. Based on the latest financial reports, Coloplast A/S (COLO-B) has total liabilities worth Dkr34.99 Billion DKK (≈ $5.47 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Coloplast A/S defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Coloplast A/S (2002–2025)
Total liabilities of Coloplast A/S from 2002 to 2025. This chart illustrates how Coloplast A/S's total liabilities have evolved over time, based on quarterly financial data. Check Coloplast A/S asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Coloplast A/S Competitors by Total Liabilities
The table below lists competitors of Coloplast A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Banco de Credito e Inversiones
SN:BCI
|
Chile | CL$74.12 Trillion |
|
Plains All American Pipeline LP
NASDAQ:PAA
|
USA | $18.82 Billion |
|
CSG N.V.
AS:CSG
|
Netherlands | €7.92 Billion |
|
PTT Exploration and Production Public Company Limited
F:NVAL
|
Germany | €455.09 Billion |
|
EchoStar Corporation
NASDAQ:ECHO
|
USA | $35.70 Billion |
|
Cellnex Telecom SA
MC:CLNX
|
Spain | €28.80 Billion |
|
Jde Peets Nv
AS:JDEP
|
Netherlands | €12.90 Billion |
|
Host Hotels & Resorts Inc
NASDAQ:HST
|
USA | $6.86 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Coloplast A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see COLO-B total assets.
Liquidity & Leverage Metrics
Coloplast A/S Total Liabilities Ratios Explained
Coloplast A/S total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Coloplast A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Coloplast A/S (2002–2025)
The table below shows the annual total liabilities of Coloplast A/S from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | Dkr32.24 Billion ≈ $5.04 Billion |
+7.02% |
| 2024-09-30 | Dkr30.13 Billion ≈ $4.71 Billion |
-2.36% |
| 2023-09-30 | Dkr30.86 Billion ≈ $4.83 Billion |
+15.74% |
| 2022-09-30 | Dkr26.66 Billion ≈ $4.17 Billion |
+247.50% |
| 2021-09-30 | Dkr7.67 Billion ≈ $1.20 Billion |
+25.93% |
| 2020-09-30 | Dkr6.09 Billion ≈ $953.29 Million |
+4.71% |
| 2019-09-30 | Dkr5.82 Billion ≈ $910.42 Million |
+8.75% |
| 2018-09-30 | Dkr5.35 Billion ≈ $837.20 Million |
-12.25% |
| 2017-09-30 | Dkr6.10 Billion ≈ $954.08 Million |
+2.68% |
| 2016-09-30 | Dkr5.94 Billion ≈ $929.20 Million |
-2.81% |
| 2015-09-30 | Dkr6.11 Billion ≈ $956.11 Million |
+49.19% |
| 2014-09-30 | Dkr4.10 Billion ≈ $640.85 Million |
+57.84% |
| 2013-09-30 | Dkr2.60 Billion ≈ $406.01 Million |
-37.23% |
| 2012-09-30 | Dkr4.13 Billion ≈ $646.79 Million |
-12.78% |
| 2011-09-30 | Dkr4.74 Billion ≈ $741.61 Million |
+9.75% |
| 2010-09-30 | Dkr4.32 Billion ≈ $675.74 Million |
-15.53% |
| 2009-09-30 | Dkr5.11 Billion ≈ $799.97 Million |
-10.14% |
| 2008-09-30 | Dkr5.69 Billion ≈ $890.24 Million |
+6.36% |
| 2007-09-30 | Dkr5.35 Billion ≈ $837.05 Million |
+3.34% |
| 2006-09-30 | Dkr5.18 Billion ≈ $809.98 Million |
+52.22% |
| 2005-09-30 | Dkr3.40 Billion ≈ $532.11 Million |
+3.87% |
| 2004-09-30 | Dkr3.27 Billion ≈ $512.29 Million |
-2.26% |
| 2003-09-30 | Dkr3.35 Billion ≈ $524.13 Million |
+14.73% |
| 2002-09-30 | Dkr2.92 Billion ≈ $456.86 Million |
-- |
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more